A Study Developing a Rapid Count for Total Bacteria in Human Intestinal Fluid

Overview

  • Study type

    Interventional
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Scottsdale/Phoenix, Arizona: 15-009608
    Sponsor Protocol Number: 15-009608

About this study

The purpose of this study is to develope a rapid lab test for counting total bacteria in human intestinal fluid collected by aspiration from the duodenal section of the small intestine.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria

  • Consecutive patients referred for elective upper endoscopy at Mayo Clinic in Arizona

Exclusion Criteria

  • Age < 18 years
  • Known pregnancy or breastfeeding

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

John DiBaise, M.D.

Closed for enrollment

Contact information:

Pompa Bhattacharjee CCRP

(480)301-4226

Bhattacharjee.Pompa@mayo.edu

.
CLS-20199178

Mayo Clinic Footer